Vilon

Overview

Vilon is a Khavinson bioregulator dipeptide (KE) consisting of lysine and glutamic acid, originally isolated from thymus gland extracts. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it acts as a molecular signaling compound that restores normal gene expression and protein synthesis in immune and epithelial cells. Research shows Vilon increases mean lifespan by 20-40% in animal studies and suppresses tumor development.

Mechanism of action

Vilon works through epigenetic modulation, restoring chromatin structure and gene expression in immune cells. It stimulates thymocyte proliferation, activates T-helper cells, and increases the proliferative index in thymus tissue (from 26% to 37% in studies). The peptide modulates tyrosine phosphorylation of mitogen-activated cytoplasmic kinases and helps rejuvenate aged immune systems by restoring proper gene expression patterns.

Key research findings

• Increases mean lifespan 20-40% in animal models
• Suppresses tumor development
• Stimulates thymocyte proliferation
• Activates T-helper cells
• Restores chromatin structure in aged lymphocytes
• Enhances intestinal barrier function
• Improves enzyme activity in aged tissue
• Part of comprehensive longevity protocols

Research applications

Immune Support

• Thymus Rejuvenation — Stimulates thymocyte proliferation and enlarges thymic lobules.
• T-Cell Activation — Activates T-helper cells and improves immune response.
• Age-Related Immune Decline — Restores chromatin structure and gene expression in aged lymphocytes.

Anti-Aging

• Lifespan Extension — Long-term treatment increased mean lifespan 20-40% in rodent studies.
• Tumor Suppression — Suppresses development of spontaneous and induced tumors.
• Tissue Regeneration — Promotes recovery in tissues exposed to radiation damage.

GI Health

• Intestinal Function — Restores brush border membrane enzyme levels in aged animals.
• Barrier Function — Enhances intestinal barrier function in aged rats.